Поиск | Myliveroom — Live Events & Online Communities

Shrikant Pawar добавлена новая статья Другое
2026-04-17 09:25:06 - Перевод -

Biosimilar Monoclonal Antibody Market Analysis Shows Increasing Regulatory Approvals
The global biosimilar monoclonal antibody market is witnessing robust growth, driven by the increasing demand for cost-effective biologic therapies and the rising burden of chronic diseases such as cancer and autoimmune disorders. The market size was valued at USD 10.71 billion in 2024 and is projected to grow from USD 12.44 billion in 2025 to USD 40.77 billion...

0 Комментарии 0 Поделились 488 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Shrikant Pawar добавлена новая статья Другое
2026-05-28 06:35:37 - Перевод -

Biosimilar Monoclonal Antibody Market Sees Expanding Applications in Autoimmune Disease Treatments
The global biosimilar monoclonal antibody market is witnessing remarkable growth due to the increasing demand for cost-effective biologic therapies and the growing burden of chronic diseases worldwide. The market was valued at USD 10.71 billion in 2024 and is projected to grow from USD 12.44 billion in 2025 to USD 40.77 billion by 2032, exhibiting a strong compound annual...

0 Комментарии 0 Поделились 112 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Jhon Kary добавлена новая статья Другое
2026-05-28 07:11:30 - Перевод -

Biosimilar Monoclonal Antibody Market Set to Triple, Reaching $40.77 Billion by 2032 as Patent Cliffs and Cost Pressures Drive Global Adoption
Kings Research has released its comprehensive analysis of the global biosimilar monoclonal antibody market, revealing that the sector is poised for extraordinary expansion over the coming seven years. Valued at USD 12.44 billion in 2025, the market is forecast to reach USD 40.77 billion by 2032, representing a compound annual growth rate (CAGR) of 18.48% — one of the highest...

0 Комментарии 0 Поделились 110 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!